Facebook

Why Facebook's algorithm change may benefit patient influencers

Why Facebook's algorithm change may benefit patient influencers

By

A WEGO Health white paper examined how the change could affect patient influencers.

What Facebook's news feed changes mean for brands and publishers

What Facebook's news feed changes mean for brands and publishers

By

Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.

MM&M's 5 most-read technology stories of 2017

MM&M's 5 most-read technology stories of 2017

By

Digital innovation in Japan, health-tech trends, and social media top the list.

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

By

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.

Facebook explains advertising policies to its users but industry wants more

Facebook explains advertising policies to its users but industry wants more

By

Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

By

Facebook itself has more than six million health-related groups.

Sheryl Sandberg: 'Facebook must bring people together to do good'

Sheryl Sandberg: 'Facebook must bring people together to do good'

By

Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.

Five things for pharma marketers to know: Tuesday, August 22, 2017

Five things for pharma marketers to know: Tuesday, August 22, 2017

By

Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit

Facebook ramps up video offer with revamped Watch tab

Facebook ramps up video offer with revamped Watch tab

By

Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.

Allergan reaches the masses via unbranded Botox Facebook page

Allergan reaches the masses via unbranded Botox Facebook page

By

In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

15 years later, a blind man sees his wedding, thanks to VR

15 years later, a blind man sees his wedding, thanks to VR

By

To demonstrate the power of goggles equipped with AR and VR, the assistive technology company recreated the event on Facebook Live this weekend.

Some CME experts remain skeptical when it comes to social media

Some CME experts remain skeptical when it comes to social media

By

There are also issues surrounding privacy and legitimacy. According to one expert's research, very few physicians use social media for professional purposes.

How VAYA Pharma used Facebook ads for its ADHD campaign

How VAYA Pharma used Facebook ads for its ADHD campaign

By

The campaign would require a two-fold approach: Facebook link ads and Facebook Audience Network.

10 ways healthcare companies are testing Instagram

10 ways healthcare companies are testing Instagram

By

Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.

How can drugmakers tell better stories? Try Instagram

How can drugmakers tell better stories? Try Instagram

By

The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.

CME providers use Facebook Live to educate doctors

CME providers use Facebook Live to educate doctors

By

A recent CME course using Facebook Live generated 34,000 views and 600 comments.

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

10 things for pharma marketers to know about Facebook and Instagram

10 things for pharma marketers to know about Facebook and Instagram

By

With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here's how.

The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study

The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study

By

The organization said it used Facebook to identify participants for a study designed to identify biomarkers associated with Parkinson's disease.

Facebook's Everson: Agencies lagging on mobile creative

Facebook's Everson: Agencies lagging on mobile creative

By

Facebook has found that 43% of people who watch the first three seconds of a video will stay for 10 seconds. To create engagement, agencies need to rethink the creative approach.

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Is It Finally Time for Pharma to Change the Way It Uses Facebook?

Pharma has hidden behind the ability to turn commenting off on Facebook pages, allowing marketers to use the channel much as they would a typical web page.

Miss Idaho shows off diabetes pump

NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."

Facebook's clinical trial

The networking site's emotion experiment rankles some in the science and political communities.

OPDP slams Facebook page

OPDP slams Facebook page

By

The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.

Business briefs: CDC, Facebook, Shire

CDC finds that non-Medicare adults make up the majority of preventable heart attack and stroke cases; a Facebook study shows groups can influence HIV screening; and a Shire ADHD drug gets a "no" from Germany

Pharmas are cool with YouTube but fear Twitter

Pharmas are cool with YouTube but fear Twitter

By

Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.

Study finds personal profiles can have professional implications

By

A recent paper shows licensing boards may take action for a professional's behavior regardless of whether it is in the context of a professional setting.

Company news: Nature Publishing Group, Elsevier, Medicare

Nature releases the Antibodypedia's seventh generation, Elsevier adds more board review apps, and how redefining "senior" may not save money in the long run

Merck takes on maternal health

Merck takes on maternal health

By

The drugmaker is focusing on two different parts of motherhood—pre and post—in dual fall campaigns that seek to emphasize preventive health across ages.

Researchers say Facebook can influence health

Researchers say Facebook can influence health

By

A teen sexual health experiment shows that Facebook can alter teen behavior.